KR

Kanchangauri Rameshkumar Akbari

Active Director Director DIN 08689507
DIN 08689507 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Kanchangauri Rameshkumar Akbari

Data last updated:

Kanchangauri Rameshkumar Akbari is a Director at Deekshant Life Science Private Limited (since 2020). The company operates in Pharma.

DIN 08689507
Primary Designation Director
Industry Pharma
First Appointment 04 Feb 2020
Oldest Company Age 6 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Feb 20202020Active

Directorship timeline

Open interactive timeline →
Deekshant Life Science Private Limited
Premium access

Shareholding and investment profile for Kanchangauri Rameshkumar Akbari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kanchangauri Rameshkumar Akbari

Kanchangauri Rameshkumar Akbari currently holds 1 directorship: Deekshant Life Science Private Limited (Director, since 04 Feb 2020).

Kanchangauri Rameshkumar Akbari was first appointed on 04 Feb 2020 as Director at Deekshant Life Science Private Limited.

The current boards of Kanchangauri Rameshkumar Akbari's companies include Dineshbhai Nanjibhai Sabhaya (Deekshant Life Science Private Limited), Jayantilal Nanjibhai Patel (Deekshant Life Science Private Limited), Karankumar Rameshbhai Akbari (Deekshant Life Science Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available